Article
p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying Genetic Risk and Defining Renal Modulatory Drugs
2026-04-19
Abstract excerpt
<title>Abstract</title> <p>Background Chronic kidney disease (CKD) affects more than 850 million individuals worldwide. Secondary genetic risk modifiers including APOL1, MYH9, GPX1, SOD2, ACE, AGT, AQP11, MBL2, PLA2R1, ABCG8, and MBOAT7 operate through mechanistically distinct pathways yet converge on identical tubulointerstitial fibrosis and end-stage kidney disease (ESKD). No unifying molecular framework expla...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 298ab57d-e22e-50ab-b2cb-aa1f2edbb2c5
- DOI
- 10.21203/rs.3.rs-9434477/v1
